Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Terns Pharmaceuticals, Inc. (TERN), dont 32 achats et 15 ventes. Le total des achats d'initiés s'élève à $14.84M et le total des ventes d'initiés à $1.33M.

Les initiés notables ayant une activité récente comprennent Kuriakose Emil, Burroughs Amy L., Fellows David A. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — TERN

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Kuriakose Emil	Chief Medical Officer	Vente Informative	942	$52.75	$49.69K	105,673
2026-03-16	Burroughs Amy L.	Chief Executive Officer	Vente Informative	2,770	$47.30	$131.03K	288,976
2026-02-17	Burroughs Amy L.	Chief Executive Officer	Vente Informative	4,083	$39.80	$162.5K	288,976
2026-02-01	Fellows David A	Director	Attribution de RSU	2,828	$34.60	$97.85K	2,828
2026-02-01	Kindler Jeffrey B	Director	Attribution de RSU	1,697	$34.60	$58.72K	1,697
2026-02-01	Turner Heather D	Director	Attribution de RSU	1,697	$34.60	$58.72K	1,697
2026-02-01	Azelby Robert	Director	Attribution de RSU	1,697	$34.60	$58.72K	1,697
2026-02-01	Tripuraneni Radhika	Director	Attribution de RSU	1,697	$34.60	$58.72K	1,697
2026-02-01	Quigley Jill M.	Director	Attribution de RSU	1,697	$34.60	$58.72K	1,697
2026-01-15	Burroughs Amy L.	Chief Executive Officer	Vente Informative	7,521	$37.53	$282.23K	288,976
2026-01-14	Gengos Andrew	Chief Financial Officer	Attribution de RSU	68,750	-	-	101,788
2026-01-14	Burroughs Amy L.	Chief Executive Officer	Attribution de RSU	150,000	-	-	288,976
2026-01-14	Kuriakose Emil	Chief Medical Officer	Attribution de RSU	56,250	-	-	106,615
2026-01-05	Burroughs Amy L.	Chief Executive Officer	Exercice d'Options (Vente)	150,000	-	-	-
2026-01-02	Burroughs Amy L.	Chief Executive Officer	Exercice d'Options	21,551	$4.64	$100K	60,315
2026-01-02	Kuriakose Emil	Chief Medical Officer	Vente Informative	955	$38.36	$36.63K	50,365
2025-11-04	Quigley Jill M.	Director	Vente Informative	24,520	$18.00	$441.36K	-
2025-10-01	Kuriakose Emil	Chief Medical Officer	Vente Informative	944	$7.85	$7.41K	51,520
2025-07-01	Kuriakose Emil	Chief Medical Officer	Vente Informative	853	$4.27	$3.64K	52,464
2025-06-27	Gengos Andrew	Chief Financial Officer	Achat Informatif	5,000	$3.93	$19.63K	20,000
2025-06-25	Burroughs Amy L.	Chief Executive Officer	Achat Informatif	23,314	$3.87	$90.23K	47,083
2025-06-16	Gengos Andrew	Chief Financial Officer	Achat Informatif	5,000	$3.95	$19.73K	15,000
2025-06-13	Gengos Andrew	Chief Financial Officer	Achat Informatif	5,000	$3.75	$18.75K	5,000
2025-06-11	Fellows David A	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-06-11	Kindler Jeffrey B	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-06-11	Turner Heather D	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-06-11	Tripuraneni Radhika	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-06-11	Lu Hongbo	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-06-11	Quigley Jill M.	Director	Attribution de RSU	45,000	$4.10	$184.5K	45,000
2025-04-01	Kuriakose Emil	Chief Medical Officer	Vente Informative	952	$2.49	$2.37K	53,317
2025-02-24	Gengos Andrew	Officer	Inconnu	-	-	-	-
2025-02-24	Gengos Andrew	Chief Financial Officer	Attribution de RSU	750,000	$3.73	$2.8M	750,000
2025-02-20	Azelby Robert	Officer	Inconnu	-	-	-	-
2025-02-20	Azelby Robert	Director	Attribution de RSU	90,000	$4.13	$371.7K	90,000
2025-02-01	Fellows David A	Director	Attribution de RSU	18,650	$4.46	$83.18K	18,650
2025-02-01	Kindler Jeffrey B	Director	Attribution de RSU	10,657	$4.46	$47.53K	10,657
2025-02-01	Tripuraneni Radhika	Director	Attribution de RSU	10,657	$4.46	$47.53K	10,657
2025-02-01	Lu Hongbo	Director	Attribution de RSU	10,657	$4.46	$47.53K	10,657
2025-02-01	Quigley Jill M.	Director	Attribution de RSU	10,657	$4.46	$47.53K	10,657
2025-02-01	Strauss David Eric	Principal Accounting Officer	Inconnu	60,000	$6.59	$395.4K	-
2025-01-30	Burroughs Amy L.	Chief Executive Officer	Attribution de RSU	1,075,000	$4.64	$4.99M	1,075,000
2025-01-30	Kuriakose Emil	Chief Medical Officer	Attribution de RSU	485,000	$4.64	$2.25M	485,000
2025-01-30	Jung Melita Sun	Chief Business Officer	Attribution de RSU	325,000	$4.64	$1.51M	325,000
2025-01-06	Vignola Mark J.	Chief Financial Officer	Vente Informative	9,059	$5.80	$52.5K	74,752
2025-01-06	Quigley Jill M.	Director	Vente Informative	8,760	$5.79	$50.76K	-
2025-01-02	Vignola Mark J.	Chief Financial Officer	Vente Informative	8,129	$5.72	$46.52K	83,811
2025-01-02	Quigley Jill M.	Director	Vente Informative	6,240	$5.72	$35.7K	8,760
2025-01-02	Kuriakose Emil	Chief Medical Officer	Vente Informative	4,481	$5.71	$25.61K	54,269
2024-12-12	Kuriakose Emil	Chief Medical Officer	Attribution de RSU	120,000	$6.59	$790.8K	120,000
2024-12-05	Burroughs Amy L.	Chief Executive Officer	Achat Informatif	15,450	$7.15	$110.47K	19,099

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration